Skip to Main Content


Clinical Programs

The Clinical Pathways Program

Photo by Getty Images

The Clinical Pathways Program aims to improve the quality of care provided to patients at Yale New Haven Children's Hospital. The Program incorporates evidence-based recommendations and expert consensus into streamlined clinical tools that outline the recommended course of treatment for various conditions, helping assure that our patients get the care they need and need the care they get. The Quality and Safety Department tracks numerous metrics to evaluate the effectiveness of the following clinical pathways in improving the overall quality of care. Visit the Clinical Pathways website on the Yale New Haven Children's Hospital Website here for more information.

Hospitalist Prenatal Consultation Program for Expectant Mothers in Medication Assisted Treatment (MAT) for Substance Use Disorders

Director: Alexis Rodriguez

Dr. Rodriguez provides telehealth consultations to expectant mothers in MAT for substance use disorders on what to expect in the hospital following delivery. Hospitalized infants with Neonatal Abstinence Syndrome (NAS) are managed with the Eat Sleep Console (ESC) approach and Dr. Rodriguez helps prepare parents on what to expect with treatment, length of stay and follow-up. Dr. Rodriguez also sees patients in NICU GRAD clinic and is studying outcomes in infants with NAS.

Yale New Haven Children’s Hospital Pediatric Ethics Committee

Chair: David Hersh

Dr. Hersh and his multi-disciplinary team provides consultation services to inpatient teams with ethical questions. The ethics committee conducts a comprehensive review and offers recommendations to both clinicians and nursing teams as well as support with working through challenging cases.